Brown Advisory’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-27,424
Closed -$144K 1210
2019
Q1
$144K Hold
27,424
﹤0.01% 1273
2018
Q4
$179K Sell
27,424
-26,500
-49% -$297K ﹤0.01% 1188
2018
Q3
$929K Sell
53,924
-500
-0.9% -$7.44K ﹤0.01% 829
2018
Q2
$759K Hold
54,424
﹤0.01% 860
2018
Q1
$834K Sell
54,424
-35,817
-40% -$512K ﹤0.01% 688
2017
Q4
$1.04M Buy
90,241
+2,384
+3% +$35.5K ﹤0.01% 666
2017
Q3
$1.67M Hold
87,857
0.01% 547
2017
Q2
$2.12M Buy
87,857
+381
+0.4% +$8.36K 0.01% 528
2017
Q1
$1.73M Buy
87,476
+53,784
+160% +$1.2M 0.01% 535
2016
Q4
$811K Sell
33,692
-43,794
-57% -$1.22M ﹤0.01% 676
2016
Q3
$2.15M Sell
77,486
-38
-0% -$1K 0.01% 491
2016
Q2
$1.89M Buy
+77,524
New +$2.2M 0.01% 497

Other funds holding PGEN

Brown Advisory's PGEN Position: Q2 2019 in Review

Brown Advisory sold out of Precigen (PGEN) in Q2 2019, closing a stake of 27,424 shares — an estimated $144K sold.

Brown Advisory first reported a position in PGEN in Q2 2016 and held it in 12 quarters. The position peaked at $2.15M in Q3 2016. 162 funds tracked by Wall St. Rank hold PGEN as of Q2 2019.

  • Brown Advisory reported no remaining Precigen position as of Q2 2019 after selling out during the quarter.
  • Brown Advisory sold 27,424 Precigen shares in Q2 2019, an estimated $144K.
  • Brown Advisory first reported a position in Precigen in Q2 2016 and held it in 12 quarters.
  • Brown Advisory's Precigen position peaked at $2.15M in Q3 2016.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q2 2019.

Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.